Enlivex Therapeutics logo

Enlivex Therapeutics Share Price Today

(NASDAQ: ENLV)

Enlivex Therapeutics share price is $1.08 & ₹94.06 as on 5 Feb 2025, 2.30 'hrs' IST

$1.08

Market is closed - opens 8 PM, 05 Feb 2025

View live Enlivex Therapeutics share price in Dollar and Rupees. Guide to invest in Enlivex Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Enlivex Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Enlivex Therapeutics share price movements

  • Today's Low: $1.05
    Today's High: $1.11

    Day's Volatility :5.41%

  • 52 Weeks Low: $0.81
    52 Weeks High: $4.59

    52 Weeks Volatility :82.35%

Enlivex Therapeutics (ENLV) Returns

PeriodEnlivex Therapeutics LtdIndex (Russel 2000)
3 Months
-14.96%
0.0%
6 Months
-12.2%
0.0%
1 Year
-58.14%
0.0%
3 Years
-78.7%
-11.7%

Enlivex Therapeutics (ENLV) Key Statistics

in dollars & INR

Previous Close
$1.08
Open
$1.11
Today's High
$1.11
Today's Low
$1.05
Market Capitalization
$24.2M
Today's Volume
$48.4K
52 Week High
$4.59
52 Week Low
$0.8101
Revenue TTM
$0.0
EBITDA
$-17.9M
Earnings Per Share (EPS)
$-0.98
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-61.17%

How to invest in Enlivex Therapeutics Stock (ENLV) from India?

It is very easy for Indian residents to invest directly in Enlivex Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Enlivex Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Enlivex Therapeutics or ENLV on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Enlivex Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Enlivex Therapeutics shares which would translate to 0.806 fractional shares of Enlivex Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Enlivex Therapeutics, in just a few clicks!

Returns in Enlivex Therapeutics (ENLV) for Indian investors in Rupees

The Enlivex Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Enlivex Therapeutics investment value today

Current value as on today

₹46,725

Returns

₹53,275

(-53.27%)

Returns from Enlivex Therapeutics Stock

₹58,140 (-58.14%)

Dollar Returns

₹4,865 (+4.86%)

Indian investors sentiment towards Enlivex Therapeutics (ENLV)

-47%

Period: Jan 5, 2025 to Feb 4, 2025. Change in 30 Days versus previous period

Search interest for Enlivex Therapeutics Stock from India on INDmoney has decreased by -47% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Enlivex Therapeutics

  • Armistice Capital, LLC

    9.73%

  • Morgan Stanley - Brokerage Accounts

    1.12%

  • Renaissance Technologies Corp

    0.34%

  • Sigma Investment Counselors Inc

    0.14%

  • XTX Topco Ltd

    0.10%

  • Goldman Sachs Group Inc

    0.06%

Analyst Recommendation on Enlivex Therapeutics

Buy

    85%Buy

    14%Hold

    0%Sell

Based on 7 Wall street analysts offering stock ratings for Enlivex Therapeutics(by analysts ranked 0 to 5 stars)

Based on 7 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
6
6
6
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Enlivex Therapeutics Stock (ENLV)

What analysts predicted

Upside of 779.63%

Target:

$9.50

Current:

$1.08

Insights on Enlivex Therapeutics Stock (Ticker Symbol: ENLV)

  • Price Movement

    In the last 1 year, ENLV stock has moved down by -60.4%
  • ENLV vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 58.6% return, outperforming this stock by 119.0%
  • ENLV vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 88.8% return, outperforming this stock by 167.0%

Enlivex Therapeutics Technicals Summary

Sell

Neutral

Buy

Enlivex Therapeutics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Enlivex Therapeutics (ENLV) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Enlivex Therapeutics Ltd logo
-12.2%
-12.2%
-58.14%
-78.7%
-86.06%
Biontech Se logo
-0.32%
51.19%
24.81%
-30.66%
288.02%
Regeneron Pharmaceuticals, Inc. logo
-6.9%
-37.55%
-28.89%
7.15%
74.63%
Vertex Pharmaceuticals Incorporated logo
16.87%
0.96%
13.03%
93.36%
95.94%
Alnylam Pharmaceuticals, Inc. logo
17.76%
5.53%
59.46%
84.7%
118.8%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Enlivex Therapeutics Ltd logo
NA
NA
NA
-0.65
-0.61
-0.27
NA
1.62
Biontech Se logo
160.8
NA
0.04
-3.32
-0.02
-0.01
NA
79.73
Regeneron Pharmaceuticals, Inc. logo
16.64
16.64
1.08
44.92
0.17
0.07
NA
272.04
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.21
0.49
-0.03
0.12
NA
60.65
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
-0.18
-15.01
-0.03
NA
0.25
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Enlivex Therapeutics Ltd logo
Buy
$24.2M
-86.06%
NA
0.0%
Biontech Se logo
Buy
$29.7B
288.02%
160.8
-15.36%
Regeneron Pharmaceuticals, Inc. logo
Buy
$74.0B
74.63%
16.64
33.61%
Vertex Pharmaceuticals Incorporated logo
Buy
$118.9B
95.94%
32.84
-4.51%
Alnylam Pharmaceuticals, Inc. logo
Buy
$35.0B
118.8%
NA
-15.86%

About Enlivex Therapeutics

Enlivex Therapeutics Ltd., together with its subsidiaries, operates as a clinical-stage macrophage reprogramming immunotherapy company in Israel. Its product pipeline is the Allocetra, which is in phase II clinical trial for the treatment of organ dysfunction caused by sepsis. The company also develops Allocetra for the treatment of moderate knee osteoarthritis and end-stage knee osteoarthritis which is in phase I/II clinical trial. Enlivex Therapeutics Ltd. is headquartered in Ness Ziona, Israel.
Organization
Enlivex Therapeutics
Employees
0
CEO
Mr. Shai Novik M.B.A.
Industry
Biotechnology

Management People of Enlivex Therapeutics

NameTitle
Mr. Shai Novik M.B.A.
Executive Chairman
Dr. Oren Hershkovitz Ph.D.
Chief Executive Officer
Ms. Shachar Shlosberger CPA
Chief Financial Officer
Mr. Veronique Amor-Baroukh
Senior Director of Operations
Ms. Sigal Arad
Director of HR

Important FAQs about investing in ENLV Stock from India :

What is Enlivex Therapeutics share price today?

Enlivex Therapeutics share price today stands at $1.08, Open: $1.11 ; Previous Close: $1.08 ; High: $1.11 ; Low: $1.05 ; 52 Week High: $4.59 ; 52 Week Low: $0.81.

The stock opens at $1.11, after a previous close of $1.08. The stock reached a daily high of $1.11 and a low of $1.05, with a 52-week high of $4.59 and a 52-week low of $0.81.

Can Indians buy Enlivex Therapeutics shares?

Yes, Indians can invest in the Enlivex Therapeutics (ENLV) from India.

With INDmoney, you can buy Enlivex Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Enlivex Therapeutics at zero transaction cost.

How can I buy Enlivex Therapeutics shares from India?

It is very easy to buy Enlivex Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Enlivex Therapeutics (ENLV) be purchased?

Yes, you can buy fractional shares of Enlivex Therapeutics with INDmoney app.

What are the documents required to start investing in Enlivex Therapeutics stocks?

To start investing in Enlivex Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Enlivex Therapeutics Stock (ENLV)?

Today’s highest price of Enlivex Therapeutics (ENLV) is $1.11.

Today’s lowest price of Enlivex Therapeutics (ENLV) is $1.05.

What is today's market capitalisation of Enlivex Therapeutics?

Today's market capitalisation of Enlivex Therapeutics ENLV is 24.2M

What is the 52 Week High and Low Range of Enlivex Therapeutics Stock (ENLV)?

  • 52 Week High

    $4.59

  • 52 Week Low

    $0.81

What are the historical returns of Enlivex Therapeutics (ENLV)?

  • 1 Month Returns

    -12.2%

  • 3 Months Returns

    -12.2%

  • 1 Year Returns

    -58.14%

  • 5 Years Returns

    -86.06%

Who is the Chief Executive Officer (CEO) of Enlivex Therapeutics ?

Mr. Shai Novik M.B.A. is the current Chief Executive Officer (CEO) of Enlivex Therapeutics.